Does DURVALUMAB Cause Chronic obstructive pulmonary disease? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Chronic obstructive pulmonary disease have been filed in association with DURVALUMAB (IMFINZI). This represents 0.3% of all adverse event reports for DURVALUMAB.
44
Reports of Chronic obstructive pulmonary disease with DURVALUMAB
0.3%
of all DURVALUMAB reports
8
Deaths
26
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From DURVALUMAB?
Of the 44 reports, 8 (18.2%) resulted in death, 26 (59.1%) required hospitalization, and 4 (9.1%) were considered life-threatening.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
Yes, Chronic obstructive pulmonary disease is listed as a known adverse reaction in the official FDA drug label for DURVALUMAB.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
MEPOLIZUMAB (1,107)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)
Which DURVALUMAB Alternatives Have Lower Chronic obstructive pulmonary disease Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE